Spanlastic-loaded FRESH printed alginate implants combine vesicle-mediated cellular delivery with matrix-governed sustained release, supporting their potential as a localized chemotherapy depot for further in vivo validation.
Doe et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: